Market Place
Sourcing Support
Preclinical Gene Editor Tome Laying Off 131 Staffers, Entire Workforce
26 Aug 2024 //
FIERCE BIOTECH
Gene Editing Biotech Tome Shrinks Operations After $213M Round
22 Aug 2024 //
FIERCE BIOTECH
Tome Programmable Genomic Integration At ASGCT
10 May 2024 //
GLOBENEWSWIRE
Tome Presenting Genomic Integration Technologies At ASGCT
23 Apr 2024 //
GLOBENEWSWIRE
Tome Biosciences granted US patent for genomic integration
09 Apr 2024 //
GLOBENEWSWIRE
Tome Biosciences Forms Science and Technology Advisory Committee
04 Mar 2024 //
GLOBENEWSWIRE
Tome Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors
30 Jan 2024 //
GLOBENEWSWIRE
Genevant Sciences to Collaborate with Tome Biosciences
16 Jan 2024 //
GLOBENEWSWIRE
Tome Biosciences Acquires Replace Therapeutics
02 Jan 2024 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.